Thomas F DeLaney

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Radiation therapy: neoadjuvant, adjuvant, or not at all
    Thomas F DeLaney
    Harvard Medical School, Boston, MA, USA
    Surg Oncol Clin N Am 21:215-41. 2012
  2. ncbi request reprint Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma
    Thomas F DeLaney
    Northeast Proton Therapy Center, Massachusetts General Hospital, 30 Fruit Street, Boston, MA 02114, USA
    Curr Treat Options Oncol 5:463-76. 2004
  3. ncbi request reprint Radiation therapy for control of soft-tissue sarcomas resected with positive margins
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 67:1460-9. 2007
  4. ncbi request reprint Advanced-technology radiation therapy for bone sarcomas
    Samir Patel
    Department of Radiation Oncology, Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston 02114, USA
    Cancer Control 15:21-37. 2008
  5. pmc Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 74:732-9. 2009
  6. doi request reprint Proton therapy in the clinic
    Thomas F DeLaney
    Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston, Mass, USA
    Front Radiat Ther Oncol 43:465-85. 2011
  7. ncbi request reprint Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas
    Thomas F DeLaney
    Northeast Proton Therapy Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Cancer Control 12:27-35. 2005
  8. ncbi request reprint Radiotherapy for local control of osteosarcoma
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 61:492-8. 2005
  9. ncbi request reprint Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center
    Thomas F DeLaney
    Division of Radiation Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA
    Technol Cancer Res Treat 6:61-6. 2007
  10. ncbi request reprint Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 56:1117-27. 2003

Detail Information

Publications59

  1. doi request reprint Radiation therapy: neoadjuvant, adjuvant, or not at all
    Thomas F DeLaney
    Harvard Medical School, Boston, MA, USA
    Surg Oncol Clin N Am 21:215-41. 2012
    ..Radiation can be delivered by external beam or brachytherapy; it can be given pre-operatively, post-operatively, or intra-operatively. Indications for and advances in radiation therapy are discussed in this article...
  2. ncbi request reprint Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma
    Thomas F DeLaney
    Northeast Proton Therapy Center, Massachusetts General Hospital, 30 Fruit Street, Boston, MA 02114, USA
    Curr Treat Options Oncol 5:463-76. 2004
    ..The clinical considerations and the outcome data that must be considered in choosing the most appropriate treatment technique for the individual patient are discussed...
  3. ncbi request reprint Radiation therapy for control of soft-tissue sarcomas resected with positive margins
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 67:1460-9. 2007
    ..Positive margins (PM) remain after surgery in some soft-tissue sarcoma (STS) patients. We investigated the efficacy of radiation therapy (RT) in STS patients with PM...
  4. ncbi request reprint Advanced-technology radiation therapy for bone sarcomas
    Samir Patel
    Department of Radiation Oncology, Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston 02114, USA
    Cancer Control 15:21-37. 2008
    ....
  5. pmc Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 74:732-9. 2009
    ..Negative surgical margins are uncommon; hence, doses of >or=66 Gy are recommended. A Phase II clinical trial evaluated high-dose photon/proton XRT for spine sarcomas...
  6. doi request reprint Proton therapy in the clinic
    Thomas F DeLaney
    Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston, Mass, USA
    Front Radiat Ther Oncol 43:465-85. 2011
    ..Together, these offer practical strategies for expanding the clinical availability of proton therapy...
  7. ncbi request reprint Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas
    Thomas F DeLaney
    Northeast Proton Therapy Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Cancer Control 12:27-35. 2005
    ..For patients with sarcomas, radiotherapy can be used as neoadjuvant, adjuvant, or primary local therapy, depending on the site and type of sarcoma, the surgical approach, and the efficacy of chemotherapy...
  8. ncbi request reprint Radiotherapy for local control of osteosarcoma
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 61:492-8. 2005
    ..Local control of osteosarcoma in patients for whom a resection with satisfactory margins is not achieved can be difficult. This study evaluated the efficacy of radiotherapy (RT) in this setting...
  9. ncbi request reprint Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center
    Thomas F DeLaney
    Division of Radiation Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA
    Technol Cancer Res Treat 6:61-6. 2007
    ..Patients' willingness to enter these clinical trials seems to be quite high; accrual to selected studies has been favorable...
  10. ncbi request reprint Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 56:1117-27. 2003
    ..We report the mature outcome data on 48 treated patients and compare them with the data of an historical matched control patient population...
  11. ncbi request reprint Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques
    Thomas F DeLaney
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 57:239-45. 2003
    ..Because a tumoricidal dose is difficult to achieve using external beam radiotherapy without exceeding the spinal cord tolerance, we developed intraoperative applicators to deliver additional dose to the dura...
  12. pmc Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study
    Nicole J Look Hong
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    Eur J Cancer 49:875-83. 2013
    ..The goal of this study is to assess outcomes in a recent cohort of patients treated on this regimen...
  13. ncbi request reprint Treatment and outcome of 82 patients with angiosarcoma
    John A Abraham
    Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B 7926, 55 Fruit Street, Boston, Massachusetts 02114, USA
    Ann Surg Oncol 14:1953-67. 2007
    ..Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites...
  14. doi request reprint Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas
    John T Mullen
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Cancer 118:3758-65. 2012
    ..We report the long-term follow-up data on 48 patients treated with this regimen compared to an historical matched-control patient population...
  15. pmc Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas
    Sam S Yoon
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 17:1515-29. 2010
    ..We sought to reduce local recurrence for retroperitoneal sarcomas by using a coordinated strategy of advanced radiation techniques and aggressive en-bloc surgical resection...
  16. doi request reprint Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone
    Timothy D Wagner
    Department of Radiation Oncology, Brooke Army Medical Center, Fort Sam Houston, TX, USA
    Int J Radiat Oncol Biol Phys 73:259-66. 2009
    ....
  17. pmc Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists
    Dian Wang
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53045, USA
    Int J Radiat Oncol Biol Phys 81:e775-80. 2011
    ..To evaluate variability in the definition of preoperative radiotherapy gross tumor volume (GTV) and clinical target volume (CTV) delineated by sarcoma radiation oncologists...
  18. ncbi request reprint Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor
    Lily Park
    Department of Radiation, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 65:1514-21. 2006
    ..To assess the efficacy of definitive treatment of sacral chordoma by high-dose proton/photon-beam radiation therapy alone or combined with surgery...
  19. doi request reprint Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center
    Andrew J Schoenfeld
    Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
    Spine (Phila Pa 1976) 37:119-26. 2012
    ..Retrospective case series...
  20. doi request reprint Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma
    Kiran Devisetty
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 02114, USA
    Int J Radiat Oncol Biol Phys 80:779-86. 2011
    ..We examined whether low-dose neoadjuvant EBRT would decrease acute toxicity while maintaining LC...
  21. doi request reprint An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control
    Bokyong Kim
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 77:843-50. 2010
    ..We retrospectively analyzed the pattern of local failure (LF) to help elucidate optimal field design...
  22. doi request reprint Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial
    Shannon M Macdonald
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 86:484-90. 2013
    ..We report acute toxicities and feasibility of proton delivery for 12 women treated with postmastectomy proton radiation with or without reconstruction...
  23. pmc Prognostic factors and outcomes of patients with myxofibrosarcoma
    Nicole J Look Hong
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:80-6. 2013
    ..The objectives of this study were to analyze the prognostic factors and outcomes of patients with MFS treated at a single institution...
  24. pmc Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions
    Martijn Engelsman
    Francis H Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02139, USA
    Int J Radiat Oncol Biol Phys 79:616-22. 2011
    ..We investigate using biological modeling if the resulting variation in daily dose to normal tissues has a relevant detrimental biological effect...
  25. doi request reprint Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA
    Ann Surg Oncol 19:4028-35. 2012
    ..Desmoid tumors are rare and exhibit a highly unpredictable natural history. We sought to analyze prognostic factors associated with recurrence in a large single-institution study of patients with desmoid tumors...
  26. pmc Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma
    I Frank Ciernik
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer 117:4522-30. 2011
    ..A study was undertaken to assess clinical outcome and the role of proton therapy for local control of osteosarcoma (OSA)...
  27. pmc Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas
    Sam S Yoon
    Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 81:1081-90. 2011
    ..We sought to examine the safety and efficacy of bevacizumab (BV) and RT in soft tissue sarcomas and explore biomarkers to help determine the treatment response...
  28. ncbi request reprint Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment
    Kevin R Kozak
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 68:1557-66. 2007
    ..To evaluate tumor and normal tissue dosimetry of a 5 cobalt gray equivalent (CGE) x 5 fraction proton radiotherapy schedule, before initiating a clinical trial of neoadjuvant, short-course proton radiotherapy for pancreatic adenocarcinoma...
  29. doi request reprint Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head
    Theodore S Hong
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 79:151-7. 2011
    ..To evaluate the safety of 1 week of chemoradiation with proton beam therapy and capecitabine followed by early surgery...
  30. doi request reprint Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas
    Ugwuji N Maduekwe
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
    Ann Surg Oncol 16:1356-63. 2009
    ..The utility of sentinel lymph node biopsy (SLNB) for patients with these sarcoma subtypes is unknown...
  31. ncbi request reprint Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques
    Kevin R Kozak
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 65:1572-8. 2006
    ..To compare the dosimetry of proton and photon-electron three-dimensional, conformal, external beam accelerated partial breast irradiation (3D-CPBI)...
  32. ncbi request reprint A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer
    Neil E Martin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 10:5447-54. 2004
    ....
  33. pmc RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies
    Dian Wang
    Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53045, USA
    Int J Radiat Oncol Biol Phys 81:e525-8. 2011
    ..To develop a Radiation Therapy Oncology Group (RTOG) atlas delineating gross tumor volume (GTV) and clinical target volume (CTV) to be used for preoperative radiotherapy of primary extremity soft tissue sarcoma (STS)...
  34. ncbi request reprint Anterior spinal arthrodesis with structural cortical allografts and instrumentation for spine tumor surgery
    Kai Uwe Lewandrowski
    Department of Orthopaedics, Massachusetts General Hospital, Boston, Massachusets, USA
    Spine (Phila Pa 1976) 29:1150-8; discussion 1159. 2004
    ..A retrospective analysis of clinical outcomes is presented...
  35. ncbi request reprint Accelerated partial-breast irradiation using proton beams: initial clinical experience
    Kevin R Kozak
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 66:691-8. 2006
    ..We present our initial clinical experience with proton, three-dimensional, conformal, external beam, partial-breast irradiation (3D-CPBI)...
  36. doi request reprint Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital
    Andrew J Schoenfeld
    Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
    Spine J 10:708-14. 2010
    ..Because of the low incidence, treatment recommendations for spinal osteosarcoma are guided by the results of small series and case reports. Many include patients who presented for treatment over the course of three to four decades...
  37. doi request reprint Management of acral myxoinflammatory fibroblastic sarcoma
    Ajay Tejwani
    Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer 116:5733-9. 2010
    ..In this report, the outcome of 17 patients with AMFS treated at the study institution was reported...
  38. pmc Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison
    Alexei Trofimov
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 69:444-53. 2007
    ..To compare intensity-modulated photon radiotherapy (IMRT) with three-dimensional conformal proton therapy (3D-CPT) for early-stage prostate cancer, and explore the potential utility of intensity-modulated proton therapy (IMPT)...
  39. ncbi request reprint Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons
    Damien C Weber
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Radiother Oncol 81:243-9. 2006
    ..To investigate the visual outcomes of patients with advanced sinonasal malignancies treated with proton/photon accelerated fractionated radiation (AFR)...
  40. pmc Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy
    Katia Parodi
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 68:920-34. 2007
    ..To investigate the feasibility and value of positron emission tomography and computed tomography (PET/CT) for treatment verification after proton radiotherapy...
  41. doi request reprint A case study in proton pencil-beam scanning delivery
    Hanne M Kooy
    F H Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 76:624-30. 2010
    ..The aim of radiotherapy is to improve the target to healthy tissue dose differential. We illustrate how PBS achieves this aim in a patient with a bulky tumor...
  42. pmc Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery
    Shannon M Macdonald
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
    Radiat Oncol 8:71. 2013
    ..This study investigates the use of protons for PMRT in selected patients with unfavorable cardiac anatomy. We also report the first clinical application of protons for these patients...
  43. ncbi request reprint Accelerated partial breast irradiation using proton beams: Initial dosimetric experience
    Alphonse G Taghian
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 65:1404-10. 2006
    ..We present our initial experience with protons for three-dimensional, conformal, external-beam accelerated partial breast irradiation (3D-CPBI)...
  44. ncbi request reprint Sarcoma and skin radiation oncology
    Elena Antoaneta Nedea
    Northeast Proton Therapy Center, Massachusetts General Hospital, 30 Fruit Street, Boston, MA 02114, USA
    Hematol Oncol Clin North Am 20:401-29. 2006
    ..Radiotherapy can be an important component of treatment in these patients. It can help optimize local control of the tumor and often allows preservation of organ function with excellent cosmesis...
  45. pmc The use of radiation therapy in the management of selected patients with atypical lipomas
    Josephine Kang
    Harvard Radiation Oncology Program, Boston, MA 02215, USA Flushing Radiation Oncology Services, Queens, NY 11354, USA
    Sarcoma 2013:485483. 2013
    ..For recurrent tumors, pre-op RT of 50 Gy appears to be an effective and well-tolerated management approach...
  46. ncbi request reprint Real-time rationing of scarce resources: the Northeast Proton Therapy Center experience
    Reshma Jagsi
    DPhil, Massachusetts General Hospital, Department of Radiation Oncology, Cox 3, 100 Blossom St, Boston, MA 02114, USA
    J Clin Oncol 22:2246-50. 2004
  47. ncbi request reprint Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report
    Alexander P Sah
    Department of Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    J Bone Joint Surg Am 89:1321-8. 2007
  48. doi request reprint Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1
    Gavin P Dunn
    Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Neurosurg 118:142-8. 2013
    ..Here, the authors aim to examine what role the extent of resection and other covariates play in the long-term survival of patients with NF1 in the setting of MPNST...
  49. pmc Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes
    Nathalie Rochet
    Department of Radiation Oncology, Massachusetts General Hospital Harvard Medical School, 100 Blossom Street, COX3, Boston, MA 02114, USA
    Radiat Oncol 8:236. 2013
    ..To evaluate feasibility and preliminary outcomes associated with sequential whole abdomen irradiation (WAI) as consolidative treatment following comprehensive surgery and systemic chemotherapy for advanced endometrial cancer...
  50. ncbi request reprint A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer
    Stephen M Hahn
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia 19104 4283, USA
    Clin Cancer Res 8:1065-72. 2002
    ..The objective of this Phase I trial was to determine the maximally tolerated dose of the FTI L-778,123 in combination with radiotherapy in non-small cell lung cancer (NSCLC) and head and neck cancer (HNC)...
  51. ncbi request reprint A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas
    Damien C Weber
    Department of Radiation Medicine, Paul Scherrer Institute, Villigen PSI, Switzerland
    Int J Radiat Oncol Biol Phys 58:1596-606. 2004
    ..Finally, a 10% and 20% dose escalation with IM protons was planned, and the consequential organ at risk (OAR) irradiation was evaluated...
  52. ncbi request reprint Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas
    Lucyna Kepka
    Department of Radiation Oncology, M Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    J Surg Oncol 92:39-45. 2005
    ..The treatment of choice, in such cases, is re-excision combined (if indicated) with radiation. However, there are clinical situations when treatment by radiation alone is recommended. Here results of such an approach are assessed...
  53. ncbi request reprint Proton beam radiation therapy
    Shannon M Macdonald
    New York University Cancer Center, New York University Medical Center, New York, USA
    Cancer Invest 24:199-208. 2006
  54. ncbi request reprint Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514
    William G Kraybill
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    J Clin Oncol 24:619-25. 2006
    ..On the basis of a positive reported single-institution pilot study, the Radiation Therapy Oncology Group initiated phase II trial 9514 to evaluate its neoadjuvant regimen in a multi-institutional Intergroup setting...
  55. ncbi request reprint Results of radiation therapy for unresected soft-tissue sarcomas
    Lucyna Kepka
    Department of Radiation Oncology, M Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    Int J Radiat Oncol Biol Phys 63:852-9. 2005
    ..Definitive radiotherapy is uncommonly used in the management of soft-tissue sarcoma (STS). The purpose of the study was to evaluate the results of radiotherapy for unresected STSs treated in a single institution...
  56. ncbi request reprint Neutron dose in proton radiation therapy: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7)
    Harald Paganetti
    Int J Radiat Oncol Biol Phys 66:1594-5; author reply 1595. 2006
  57. ncbi request reprint Diagnosis of sarcoma by core biopsy
    Thomas F DeLaney
    J Surg Oncol 94:1-2. 2006
  58. ncbi request reprint Musculoskeletal desmoid tumors
    Harish S Hosalkar
    Department of Orthopaedic Surgery, University of Pennsyvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    J Am Acad Orthop Surg 16:188-98. 2008
    ..Chemotherapy in low doses is an excellent first-round treatment in any patient in whom contemplated local treatment may produce local morbidity and adjacent tissue injury...
  59. ncbi request reprint Soft tissue sarcoma
    George D Demetri
    Dana Faber Brigham and Women s Cancer Center, USA
    J Natl Compr Canc Netw 5:364-99. 2007